Search clinical trials for: fundus diseases

Total 374893 results

Laboratoires Thea

Completed

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial

France
Tufts University
National Institutes of Health (NIH)

Completed

Effect of Calcium and Vitamin D on Bone Loss From the Hip

Osteoporosis

United States
Medical University of Vienna

Completed

Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery

Atherosclerosis

Austria
National Center for Complementary and Integrative...

Completed

Valerian to Improve Sleep in Patients With Parkinson's Disease

Parkinson's Disease | Insomnia

United States
Laboratoires Thea

Completed

Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

Trachoma
Gachon University Gil Medical Center

Completed

Safety and Effects of Ramipril Combined With Candesartan

Hypertension
University Hospital Freiburg
Almased Wellness GmbH

Completed

Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.

Obesity | Metabolic Syndrome

Germany
Laboratoires Thea

Completed

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers

Eye Infections, Bacterial
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
National Center for Complementary and Integrative...

Completed

High Intensity Light Therapy in Alzheimer's Disease

Dementia | Alzheimer's Disease

United States
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Charite University, Berlin, Germany

Unknown

HAI Via Interventionally Implanted Port Catheter Systems

Liver Neoplasms | Hepatocellular Carcinoma | Colorectal Cancer | Bile Duct Cancer | Gallbladder Cancer

Germany
Pfizer

Completed

CP-481,715 Nickel Allergy Study.

Dermatitis, Allergic Contact

United States, Denmark
Azienda Ospedaliera San Giovanni Battista

Terminated

Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Italy
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
A.O. Ospedale Papa Giovanni XXIII

Completed

BASTA Study on STI in HIV Infected Patients

HIV Infection

Italy
Tripler Army Medical Center

Unknown

Comparison of Body and Room Temperature Saline in Urodynamics

Urinary Incontinence

United States
Pfizer

Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Epilepsies, Partial | Epilepsy, Complex Partial

Spain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Carcinoma, Non-Small-Cell Lung

Russian Federation
General Hospital Sveti Duh

Completed

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

End Stage Renal Disease | Renal Anemia | Regular Dialysis Treatment

Croatia
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants

Necrotizing Enterocolitis

United States
University of Surrey
British Broadcasting Corporation

Completed

The Effectiveness of Commercial Weight Loss Programmes

Obesity

United Kingdom
Kamuzu University of Health Sciences

Completed

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Status Epilepticus | Convulsions

Malawi
Wageningen Centre for Food Sciences
SEAFOODplus

Completed

SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia

Arrhythmia

United Kingdom, Netherlands, Germany, Poland, Belgium, Austria, Czech Republic, Switzerland
International Centre for Diarrhoeal Disease Research...
Pfizer; Tufts Medical Center

Completed

Single Dose Azithromycin in the Treatment of Adult Cholera

Cholera

Bangladesh
Hoersholm Hospital
GlaxoSmithKline

Completed

Epidemiology Study in Major Orthopaedic Surgery

Quality of Life | Postoperative Complications | Thrombosis

Denmark
Drug Commission of the German Medical Association
Madaus AG

Terminated

Cholesterol-Lowering Effects of Policosanol

Hypercholesterolemia | Combined Hyperlipidemia
National Taiwan University Hospital
Palo Alto Medical Foundation

Unknown

Develop Biomarkers for Assessing RA Joint Erosion

Rheumatoid Arthritis

Taiwan
Eli Lilly and Company

Completed

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Lung Neoplasms

United States
Eli Lilly and Company

Completed

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

United States
Eli Lilly and Company

Completed

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

Alzheimer's Disease

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms

Finland, France, Germany
National Eye Institute (NEI)

Completed

Laser and Medical Treatment of Diabetic Macular Edema

Macular Degeneration

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Pancreatic Neoplasms | Metastases, Neoplasm

United States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
Eli Lilly and Company

Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Carcinoma, Non-Small-Cell Lung | Neoplasms, Lung | Pulmonary Neoplasms

United States
University of Waterloo
Alcon Research

Completed

Contact Lens Wettability

Ametropia

Canada
Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

EVA: Evista Alendronate Comparison

Osteoporosis

United States, Canada
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Argentina, Belgium, Brazil, Mexico, Portugal
Eli Lilly and Company

Completed

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Eli Lilly and Company

Completed

Comparing 3 Schedules of Alimta Plus Gemzar

Neoplasms | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Eli Lilly and Company

Completed

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Breast Neoplasms

United States
Eli Lilly and Company

Completed

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Breast Neoplasms

United States, Argentina, Chile, India, Mexico
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Colorectal Cancer

United States

Search clinical trials for: fundus diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations